» Articles » PMID: 27926944

Targeting Neutrophils to Prevent Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome in Mice

Abstract

Malaria remains one of the greatest burdens to global health, causing nearly 500,000 deaths in 2014. When manifesting in the lungs, severe malaria causes acute lung injury/acute respiratory distress syndrome (ALI/ARDS). We have previously shown that a proportion of DBA/2 mice infected with Plasmodium berghei ANKA (PbA) develop ALI/ARDS and that these mice recapitulate various aspects of the human syndrome, such as pulmonary edema, hemorrhaging, pleural effusion and hypoxemia. Herein, we investigated the role of neutrophils in the pathogenesis of malaria-associated ALI/ARDS. Mice developing ALI/ARDS showed greater neutrophil accumulation in the lungs compared with mice that did not develop pulmonary complications. In addition, mice with ALI/ARDS produced more neutrophil-attracting chemokines, myeloperoxidase and reactive oxygen species. We also observed that the parasites Plasmodium falciparum and PbA induced the formation of neutrophil extracellular traps (NETs) ex vivo, which were associated with inflammation and tissue injury. The depletion of neutrophils, treatment with AMD3100 (a CXCR4 antagonist), Pulmozyme (human recombinant DNase) or Sivelestat (inhibitor of neutrophil elastase) decreased the development of malaria-associated ALI/ARDS and significantly increased mouse survival. This study implicates neutrophils and NETs in the genesis of experimentally induced malaria-associated ALI/ARDS and proposes a new therapeutic approach to improve the prognosis of severe malaria.

Citing Articles

Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury.

Kim J, Seo D, Yoo S, Lee H, Kim J, Yeom J Nano Converg. 2025; 12(1):8.

PMID: 39894864 PMC: 11788270. DOI: 10.1186/s40580-025-00475-4.


Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study.

Li Y, Zhao J, Wei J, Zhang Y, Zhang H, Li Y Respir Res. 2025; 26(1):28.

PMID: 39827089 PMC: 11743030. DOI: 10.1186/s12931-025-03100-4.


Apoptotic Vesicles Attenuate Acute Lung Injury CD73-Mediated Inhibition of Platelet Activation and NETosis.

Tan L, Zhang C, Kou X, Zhao L, Wu D, Li J Int J Nanomedicine. 2025; 20():91-107.

PMID: 39802376 PMC: 11717653. DOI: 10.2147/IJN.S485012.


Neutrophil Extracellular Traps Drive Kidney Stone Formation.

Yang Z, Chen X, Qi G, Gu J, Liu Z, Zhang X Kidney Dis (Basel). 2025; 11(1):11-24.

PMID: 39759764 PMC: 11695979. DOI: 10.1159/000542471.


Exploration of key mechanisms underlying the therapeutic effects of AMD3100 on attenuating lipopolysaccharide-induced acute lung injury in mice.

Lv Z, Zhang B, Zhang H, Mao Y, Yu Q, Dong W PeerJ. 2024; 12:e18698.

PMID: 39677961 PMC: 11646417. DOI: 10.7717/peerj.18698.


References
1.
Erdeve O, Uras N, Atasay B, Arsan S . Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series. Croat Med J. 2007; 48(2):234-9. PMC: 2080511. View

2.
Drummond S, Ramachandran S, Torres E, Huang J, Hehre D, Suguihara C . CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats. Neonatology. 2015; 107(4):304-11. PMC: 4458217. DOI: 10.1159/000371835. View

3.
Caudrillier A, Kessenbrock K, Gilliss B, Nguyen J, Marques M, Monestier M . Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012; 122(7):2661-71. PMC: 3386815. DOI: 10.1172/JCI61303. View

4.
Costa F, Lopes S, Albrecht L, Ataide R, Siqueira A, Souza R . On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field. Int J Parasitol. 2012; 42(12):1099-105. DOI: 10.1016/j.ijpara.2012.08.007. View

5.
Mohan A, Sharma S, Bollineni S . Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis. 2008; 45(3):179-93. View